Magic mushroom therapy takes on tough depression
NCT ID NCT06303739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can help people with depression that hasn't improved with standard treatments. Twenty adults will receive one or two doses and be followed for a year to see if their symptoms get better and how long any improvement lasts. The goal is to ease depression symptoms, not to cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UNC Chapel Hill Medical Center
Chapel Hill, North Carolina, 27514, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain 'Radio' tunes into Depression's neural signals
- Magic mushroom compound tested for dual relief of chronic pain and depression
- Ketamine plus talk therapy shows promise for stubborn depression
- Brain zaps guided by scans: a new hope for untreatable depression?
- Magic mushroom compound may offer new hope for stubborn depression
- Can a blood test predict who will respond to ketamine for depression?